At visit 1 (V1), 24 arthritis rheumatoid (RA) individuals received an initial therapeutic decision that corresponded to the next options: decrease infliximab dosage; same infliximab medication dosage plus another involvement; increase infliximab medication dosage; discontinue infliximab; and change to some other treatment
At visit 1 (V1), 24 arthritis rheumatoid (RA) individuals received an initial therapeutic decision that corresponded to the next options: decrease infliximab dosage; same infliximab medication dosage plus another involvement; increase infliximab medication dosage; discontinue infliximab; and change to some other treatment. and V4 and weighed against those at V1. == Outcomes == We included … Read more